BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AMALGENT THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

AMALGENT THERAPEUTICS

via PROSPERING SOLUTIONS, LLC FKA JOHN C. SNYDER III

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 20, 2026Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: AMALGENT THERAPEUTICS
Description: medical testing
Location: North Carolina · United States of America

Registrant

Firm: PROSPERING SOLUTIONS, LLC FKA JOHN C. SNYDER III
Location: Charlotte, North Carolina, United States of America

Lobbying activities

1 issue

Defense
Defense medical testing funding
LobbyistsJOHN SNYDER
TargetedDefense, Dept of (DOD)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.